‘Female viagra’ fails to arouse, causes dizziness

US health regulators said yesterday that the first pill designed to boost the female sex drive failed to make a significant impact on libido in two studies.

Despite missing that goal, the Food and Drug Administration said women did report slightly more satisfaction in their sexual experiences.

Boehringer Ingelheim has asked the FDA to approve its drug flibanserin for women who report a lack of sexual desire, a market that drug makers have been targeting for more than a decade since the success of Viagra in men.

The search for so-called “female Viagra” has proved elusive, with many drugs abandoned after lacklustre results.

Tomorrow the FDA will ask a panel of experts to weigh in on the safety and effectiveness of Boehringer’s drug. The agency is not required to follow the group’s advice though it often does.

The FDA will also askexperts to comment on increased side effects likedepression, fainting and dizziness among women taking the pill.

The drug, which is related to the antidepressant family, affects serotonin and several other brain chemicals, though it is not clear how that increases sex drive.

“We don’t know specifically what the exact mechanism of action is, but we believe it acts on brain chemicals that have a role inhuman sexual response,” said Peter Piliero, executivedirector for Boehringer’s US medical affairs.

Since the launch of Viagra in 1998, more than two dozen experimental therapies have been studied for so-called “female sexual dysfunction”, a market which some analysts estimate at $2 billion (€1.6bn) .

In 2004, Pfizer halted its study of Viagra in women due to inconclusive results. Later that year an FDA panel rejected Procter & Gamble’s testosterone patch Intrinsa, due to risks of heart disease and cancer.

Elizabeth Kavaler, a urologist at Lenox Hill Hospital in New York, says arousal in women is so complicated it may be unrealistic to expect a pill to completely address sexual problems. “It’s a fairly complicated area, unlike in men’s sexual dysfunction.

“In women there’s no mechanical concern, so if she’s not having a successful sex life, where is the problem?”